ORIEL RESEARCH SERVICES LIMITED

Oriel Research Therapeutics (ORT) is a cutting‑edge bioinformatics company that turns vast, real‑world patient‑derived genomic data into actionable insights for the life‑science and healthcare sectors. Leveraging a cloud‑based software platform, ORT harmonises and processes large‑scale omic datasets—most notably more than one million RNA‑seq profiles from both in‑vivo and in‑vitro samples—paired with detailed clinical information. This rich, curated database is then interrogated with the company’s proprietary artificial‑intelligence and machine‑learning models to support early‑detection tests for cancer and other diseases, as well as AI‑driven model development.

Key services include rapid access to the ORT database, bespoke AI/ML pipeline deployment, and evidence‑based hypothesis generation for diagnosis, therapy matching and target discovery. By offering a seamless interface to harmonised real‑world data, ORT enables researchers, pharmaceutical developers and clinicians to accelerate translational projects and bring precision‑medicine solutions to market more efficiently.

Founded by Eila Arich ME, a veteran of Microsoft, Technion, Broad Institute, MGH, Whitehead Institute and Stanford, and co‑led by Dr Noam Shoresh, a Harvard‑trained bioinformatician, Oriel Research Therapeutics builds on its heritage as a J&J Innovation Lab alumni, combining deep scientific expertise with robust engineering to drive the next generation of data‑powered healthcare.